OSCR

Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy.

Overview

Authors: Kathy L. Poulin1, Charlotte A. René1,2,3, Ian C. Smith4, Panayiotis O. Vacratsis5, Dylan Burger6,7,8, Hugh J. McMillan9, Rashmi Kothary1,3,8,10, Theodore J. Perkins1,2,3, Jodi Warman-Chardon3,4,8,10,11,12, Robin J. Parks1,2,3,10
ORCID iDs: Robin J. Parks
  1. Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada
  2. Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
  3. Centre for Neuromuscular Disease, University of Ottawa, Ottawa, ON K1H 8M5, Canada
  4. NeuroMuscular Centre, The Ottawa Hospital, Ottawa, ON K1Y4E9, Canada
  5. Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON N9B3P4, Canada
  6. Inflammation and Chronic Disease Program, Kidney Research Centre, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada
  7. School of Pharmaceutical Sciences, University of Ottawa, Ottawa, ON K1H 8M5, Canada
  8. Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada
  9. Department of Pediatrics, Children’s Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON K1H 8L1, Canada
  10. Department of Medicine, The Ottawa Hospital and University of Ottawa, Ottawa, ON K1H 8L6, Canada
  11. Neuroscience Program, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada
  12. Department of Genetics, Children’s Hospital of Eastern Ontario, Ottawa, ON K1H 8L1, Canada
Journal: Molecular therapy. Advances, volume 34, issue 2, article 201757
Dates: received 26 September 2025; accepted 8 May 2026; published online 13 May 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1016/j.omta.2026.201757 · PMID 42232219 · PMCID PMC13224364 · OpenAlex W7161116725
Open access: hybrid, a free copy (OpenAlex)
Status: code on request (how the code is found and verified)
Categories: genetics / omics (modality), human (organism), other condition (population)
Keywords: spinal muscular atrophy, extracellular vesicle, nusinersen, proteomics, plasma, cerebrospinal fluid
Topic: Neurogenetic and Muscular Disorders Research (Genetics (clinical), Medicine), according to OpenAlex
Funding: Canadian Institutes of Health Research (PJT-178120, NHG-107767, MOP-136898, PYY-175428); Cure SMA/Cure SMA Canada; Queen Elizabeth II Graduate Scholarship in Science and Technology from the Ontario Provincial Government (Canada)
Citations: not cited yet (Europe PMC); 129 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

No dataset and no data link were found in the paper.

Code and data availability statement

The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

  • it says that the data are available on request
  • it says that the code is available on request

Read it in the paper: doi.org/10.1016/j.omta.2026.201757.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Authors: added Robin J. Parks (0000-0002-4959-2233); removed Robin J. Parks

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 10 authors, 6 keywords, 3 funders, 129 references.

Cite

This paper

Poulin, K. L., René, C. A., Smith, I. C., Vacratsis, P. O., Burger, D., McMillan, H. J., Kothary, R., Perkins, T. J., Warman-Chardon, J., & Parks, R. J. (2026). Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy. Molecular therapy. Advances, 34(2), 201757. https://doi.org/10.1016/j.omta.2026.201757

BibTeX

@article{poulin2026extracellular,
author = {Poulin, Kathy L. and René, Charlotte A. and Smith, Ian C. and Vacratsis, Panayiotis O. and Burger, Dylan and McMillan, Hugh J. and Kothary, Rashmi and Perkins, Theodore J. and Warman-Chardon, Jodi and Parks, Robin J.},
title = {{Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy}},
journal = {Molecular therapy. Advances},
year = {2026},
month = may,
volume = {34},
number = {2},
pages = {201757},
publisher = {American Society of Gene \& Cell Therapy},
issn = {3117-387X},
doi = {10.1016/j.omta.2026.201757},
url = {https://doi.org/10.1016/j.omta.2026.201757},
pmid = {42232219},
pmcid = {PMC13224364}
}

RIS

TY - JOUR
AU - Poulin, Kathy L.
AU - René, Charlotte A.
AU - Smith, Ian C.
AU - Vacratsis, Panayiotis O.
AU - Burger, Dylan
AU - McMillan, Hugh J.
AU - Kothary, Rashmi
AU - Perkins, Theodore J.
AU - Warman-Chardon, Jodi
AU - Parks, Robin J.
TI - Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy
T2 - Molecular therapy. Advances
J2 - Mol Ther Adv
PY - 2026
DA - 2026/05/13
VL - 34
IS - 2
SP - 201757
SN - 3117-387X
PB - American Society of Gene & Cell Therapy
DO - 10.1016/j.omta.2026.201757
UR - https://doi.org/10.1016/j.omta.2026.201757
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.omta.2026.201757",
"type": "article-journal",
"title": "Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy",
"container-title": "Molecular therapy. Advances",
"author": [
{
"family": "Poulin",
"given": "Kathy L."
},
{
"family": "René",
"given": "Charlotte A."
},
{
"family": "Smith",
"given": "Ian C."
},
{
"family": "Vacratsis",
"given": "Panayiotis O."
},
{
"family": "Burger",
"given": "Dylan"
},
{
"family": "McMillan",
"given": "Hugh J."
},
{
"family": "Kothary",
"given": "Rashmi"
},
{
"family": "Perkins",
"given": "Theodore J."
},
{
"family": "Warman-Chardon",
"given": "Jodi"
},
{
"family": "Parks",
"given": "Robin J."
}
],
"container-title-short": "Mol Ther Adv",
"volume": "34",
"issue": "2",
"page": "201757",
"DOI": "10.1016/j.omta.2026.201757",
"PMID": "42232219",
"PMCID": "PMC13224364",
"ISSN": "3117-387X",
"publisher": "American Society of Gene & Cell Therapy",
"URL": "https://doi.org/10.1016/j.omta.2026.201757",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
13
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1126/science.adg6518 [code]
Base editing rescue of spinal muscular atrophy in cells and in mice.
Journal: Science (New York, N.Y.)
In common: other condition, 13 references
[2] doi:10.1016/j.xcrm.2024.101659 [code]
Isogenic patient-derived organoids reveal early neurodevelopmental defects in spinal muscular atrophy initiation.
Journal: Cell reports. Medicine
In common: other condition, 11 references
[3] doi:10.1002/1873-3468.70303
Organ-specific redox imbalances in spinal muscular atrophy mice are partially rescued by SMN antisense oligonucleotides.
Journal: FEBS letters
In common: other condition, 10 references
[4] doi:10.1038/s41467-026-73545-8
Long-term comparative analysis of AAV9-mediated gene replacement therapies for spinal muscular atrophy in mice.
Journal: Nature communications
In common: other condition, 9 references
[5] doi:10.1038/s44321-025-00303-6
Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy.
Journal: EMBO molecular medicine
In common: other condition, 8 references
[6] doi:10.1007/s00401-024-02709-x
Alteration of LARGE1 abundance in patients and a mouse model of 5q-associated spinal muscular atrophy.
Journal: Acta neuropathologica
In common: genetics / omics, other condition, 7 references
[7] doi:10.1002/jev2.12397
Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies.
Journal: Journal of extracellular vesicles
In common: 7 references
[8] doi:10.1016/j.isci.2025.112461 [code]
Comprehensive analysis across <i>SMN2</i> excludes DNA methylation as an epigenetic biomarker for spinal muscular atrophy.
Journal: iScience
In common: genetics / omics, other condition, 6 references
[9] doi:10.1038/s41413-025-00473-6
SMN deficiency inhibits endochondral ossification via promoting TRAF6-induced ubiquitination degradation of YBX1 in spinal muscular atrophy.
Journal: Bone research
In common: genetics / omics, other condition, 6 references
[10] doi:10.1172/jci.insight.158380
Bap1/SMN axis in Dpp4+ skeletal muscle mesenchymal cells regulates the neuromuscular system.
Journal: JCI insight
In common: 6 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.